| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |